antioxidative skin cell protection fertility pain liver kidneys herpes diabetes brain tumor digestion metabolism cholesterol cancer radiation protection antiviral teeth joints germs gout blood circulation wound healing anti-inflammatory heart bacteria parasites alzheimer telomere general oxygen

Potential effects of Haritaki on cholesterol

Terminalia Chebula: Cholesterol

Scientific experiments and studies on potential effects of Haritaki on cholesterol.

Haritaki has been suggested to have a potential supportive effect in lowering lipid levels. Animal studies showed that treatment with Haritaki could potentially lead to a reduction in total cholesterol, triglycerides, total protein, and an increase in high-density lipoprotein cholesterol.

Please note: As we are not permitted to make specific statements about health effects due to EU regulations, we would like to refer to relevant secondary literature, which can be found, for example, in the PubMed database or the National Library of Health. We recommend searching with the term “Terminalia Chebula.”

At present, there is no scientifically confirmed health benefit of Haritaki recognized by the EFSA (EU Authority for Science, Safe Food, and Sustainability). The described experiences are based on traditional applications and individual reports. The available scientific studies should therefore be evaluated and interpreted individually.

Hypolipidemic activity of haritaki (terminalia chebula) in atherogenic diet induced hyperlipidemic rats

Source: Journal of Advanced Pharmaceutical Technology Research 2010 Apr;1(2):229-35.

Quote from the study: Haritaki (Terminalia chebula) family Combretaceae is an important plant used traditionally for medicinal purposes. It is component of the classic Ayurvedic combination called "Triphala". Hyperlipidemia was induced by treated orally with atherogemc diet. In atherogenic diet induced hyperlipidemic model, the rats receiving treatment with Haritaki showed significant reduction in total cholesterol, triglycerides, total protein and elevation of high density lipoprotein cholesterol. Haritaki was found to possess significant hypolipidemic activity. The results also suggest that Haritaki at 1.05 and 2.10 mg/kg b.wt. concentrations are an excellent lipid-lowering agent."

[Link to the scientific study]

Hypocholesterolemic effect of Terminalia chebula fruit (Myrobalan) in mice

Source: Ancient Science of Life . 2004 Apr;23(4):11-5.

Quote from the study: Cholesterol fed mice were administered powdered myrobalan, the fruit of Terminalia chebula, to evaluate its antiatherogenic activity. Male mice were fed a diet containing 1% cholesterol with or without myrobalan for 100 days. The cholesterol containing diet fed to mice caused increased food intake, body weight, serum cholesterol, triglyceride, thickening of the walls of aorta and shrinkage in its lumen (group 2) . The oral administration of myrobalan to mice on atherogenic diet successfully reversed these effect (group 3). However, the food intake was observed to be high as compared to the control animals. Control animals (group 1) received only the vehicle. The results suggest that myrobalan has hypocholesterolemic effect in animals fed with atherogenic diet."